Author: Anlon

Anlon is a research-intensive organization which is into manufacturing of APIs and intermediates, process control instruments and pharmaceutical products. Based in Rajkot in Gujarat in India, ANLON Group has already earned a global recognition for manufacturing products that adhere to the highest standards of quality. ANLON Group has three major divisions - Anlon Healthcare Private Limited is into manufacturing of API and its intermediates, while Anlon Technology Research Organization is into manufacturing of process control and automation instruments and Anlon Lifescience Private Limited is engaged into multi dimensional modern pharmaceutical products. Anlon Healthcare Private Limited has gained competency in Organic Synthesis and Process Development complying regulatory requirements of leading health authorities such as FDA, PMDA, KFDA, cGMP, WHO-GMP. With exceptional Research and Development (R&D) capabilities, advanced API manufacturing facilities, global regulatory accreditations, a strong product pipeline and speed-to-market competencies, Anlon Healthcare Private Limited has already created a niche in APIs and Intermediates production market and can be considered an ideal API partner for any bulk drag manufacturing need. Anlon Healthcare Private Limited offers technical and regulatory support across the entire production process, from project initiation to final production. Manufacturing facility of Anlon Healthcare Private Limited is equipped with high precision instruments that build quality at every stage of the process. Owing to the emerging competitive climate of the pharmaceutical industry, Anlon Healthcare Private Limited has remain proactive in discerning ways to continually add customer value and augment its competency in business. Anlon Technology Research Organization is a brain trust of impassioned technocrats who thrive on creating groundbreaking ideas to manufacture Process Control and Automation Instruments pertaining to a wide range of applications and has been providing ingenious manufacturing solutions to our clientele around the world. Since its genesis, Anlon Technology Research Organization has helped businesses meet revolutionary changes in a fast moving knowledge economy. The array of customizable, versatile and highly efficient instruments assures productivity and sustainability. Since its inception, Anlon Technology Research Organization has earned proficiency in product design, product development and testing through extensive market and intensive scientific research. The state-of-the-art R&D facility with dedication of engineers creates a distinctive advantage for Anlon TRO. Anlon Lifescience Private Limited is multi dimensional modern pharmaceutical company with profound manufacturing skills, in-depth marketing strategic insight and leading exporter for healthcare products. The objective of the company is to research, develop, manufacture, and market new medicines, nutraceuticals and cosmetics of high quality at affordable price for patients across the globe. Anlon Lifescience Private Limited has state-of-the-art formulation manufacturing units, adhering to international standards and regulations. With in deep scientific knowledge, Anlon Lifescience Private Limited ensures that medicines are formulated from highest quality API and Excipients. With sound technical knowledge Anlon Lifescience Private Limited ensures that all formulations are up to the standard in size, shape, weight, color and related physical properties. Anlon Lifescience Private Limited periodically upgrades technology, automated machines and instruments to match up to exponential global demand of formulations. To know more about Anlon, please log on to: www.anlon.in

ANLON Lifesciene requires Medical Representatives

Anlon Lifescience Private Limited, formulation division of Anlon Group is into research, develop, manufacture, and market new medicines, nutraceuticals and cosmetics of high quality at affordable price for patients across the globe. Anlon Lifescience is multi dimensional modern pharmaceutical company with profound manufacturing skills, in-depth marketing strategic insight and leading exporter for healthcare products. Anlon … Continue reading ANLON Lifesciene requires Medical Representatives →

MoU between India and Indonesia may boost pharma export from India, says Anlon

Rajkot (Gujarat, India), Friday, July 20, 2018: The Union Cabinet chaired by the Prime Minister Mr. Narendra Modi has given its ex-post facto approval for the Memorandum of Understanding (MoU) between the Central Drugs Standard Control Organization (CDSCO), India and National Agency for Drug and Food Control (BPOM), Indonesia on cooperation in the field of … Continue reading MoU between India and Indonesia may boost pharma export from India, says Anlon →

China again announces slashing of import duties on drugs from India

China agrees to slash import duty on Cancer drugs from India. Chinese authorities have announced of slashing import duties on drugs from India twice in as many months. Removing import duty on drugs from India is to reduce bilateral trade deficit or to mitigate need of medicines in China. Answers Punit Rasadia Recently, Spokesperson of … Continue reading China again announces slashing of import duties on drugs from India →

Anlon Healthcare: working hard for healthier tomorrow

Anlon Healthcare: working hard for healthier tomorrow To harness the strength of technology and research into becoming a leading global pharmaceutical company that delivers maximum consumer satisfaction. Innovation is seen what everybody has seen and thinking of what nobody has thought. Change is called for an innovation and innovation leads to progress. With this very … Continue reading Anlon Healthcare: working hard for healthier tomorrow →

Closed Chinese factories, soaring Dollar rate; Indian Pharma Cos experience double blows

Closed Chinese factories, soaring Dollar rate Indian Pharma Cos experience double blow Rajkot (Gujarat, India), Monday, July 16, 2018: Indian pharmaceutical industry is passing through turbulence phase created because of two external phenomenons – closure of Chinese factories and soaring dollar exchange rate with INR, said Anlon. Mr. Punit Rasadia, Managing Director of Rajkot based … Continue reading Closed Chinese factories, soaring Dollar rate; Indian Pharma Cos experience double blows →

Anlon launches gel based Torrid Plus for instant pain relief

Ahmedabad (Gujarat, India), Wednesday, July 4, 2018: Keeping the football fever on during the ongoing FIFA World Cup, Rajkot based pharmaceuticals startup, Anlon Lifescience has launched over-the-counter “Torrid - Plus” for instant pain relief here on today.  The gel based instant pain reliever works like a wonder on joints pain, sprains and strains, muscular pain, … Continue reading Anlon launches gel based Torrid Plus for instant pain relief →

Indian drug manufacturers can take advantage of shutdown of Chinese pharma companies

There is a huge demand of APIs and Intermediates in China and Indian manufacturers should be in a position to fulfill the demand-supply gap created in the Chinese market writes Punit Rasadia According to a research report titled "The Effect of Environmental Regulation on Employment in Resource-Based Areas of China—An Empirical Research Based on the … Continue reading Indian drug manufacturers can take advantage of shutdown of Chinese pharma companies →

Anlon advocates for “Listen First” to create awareness against drug abuse

Scene 1: A 59-year-old woman was stabbed to death allegedly by her brother following an argument over his drug addiction in west Delhi's Vikaspuri area on June 24, 2018. Scene 2: Four drug addicts allegedly murdered one of the inmates of an illegal drug de-addiction centre being run in Matoi village in Malerkotla subdivision in … Continue reading Anlon advocates for “Listen First” to create awareness against drug abuse →

IBC Ordinance 2018: much awaited relief for MSME

IBC Ordinance 2018: much awaited relief for MSME By Punit Rasadia The President of India has recently given his consent to promulgate the Insolvency and Bankruptcy Code (Amendment) Ordinance, 2018. The IBC Ordinance 2018 provides significant relief to home buyers by recognizing their status as financial creditors.  This would give them due representation in the … Continue reading IBC Ordinance 2018: much awaited relief for MSME →

Anlon to participate in CPhI in China

Rajkot (Gujarat), Tuesday, June 19, 2018: Rajkot based Anlon Healthcare Private Limited, is going to participate in the forthcoming CPhI China scheduled from June 20- 22, 2018 at the Shanghai New International Expo Center.  CPhI China is one of the leading Global Exhibitions in which all major bulk drug, Intermediates and Pharmaceutical manufacturers participate. Mr. … Continue reading Anlon to participate in CPhI in China →